We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Communications During PDUFA VI Reviews Generally Good, Industry Says
FDA Communications During PDUFA VI Reviews Generally Good, Industry Says
Fee-paying drug sponsors who submit investigational new drug (IND) applications to the FDA generally get high-quality responses and communications from the agency, according to an independent assessment by Lexington, Mass.-based Eastern Research Group.